Lavo AI — AI Crystal Structure Prediction

Lavo AI is an AI-powered crystal structure prediction platform for pharmaceutical drug development teams

Lavo AI provides cloud-based crystal structure prediction (CSP) to accelerate drug development for pharmaceutical companies. This platform is designed for research teams and formulation scientists who need to identify stable solid-state forms of small molecule drugs early in the development cycle. By simulating molecular interactions at an atomic level, the software predicts how drug molecules will organize into crystals, which is critical for ensuring drug stability and patent protection. Lavo AI enables teams to de-risk their pipelines by identifying potential polymorphic transitions that could lead to manufacturing failures or regulatory delays. The system automates the search for stable crystal forms, providing a faster alternative to traditional trial-and-error laboratory screening. Business owners in the life sciences sector can use these insights to optimize solid-state formulations and improve the overall manufacturability of their products. Integrating advanced computational chemistry with high-performance computing, Lavo AI helps companies avoid late-stage surprises that often derail clinical trials. Users can explore the platform features and verified data on surfai.app to understand how AI-driven simulation reduces the time spent on physical experimentation. The solution assists in securing intellectual property by discovering a wider range of novel polymorphs. The platform is available via a freemium model with introductory access for researchers and academic projects. Larger pharmaceutical organizations can access enterprise-level simulation capacity through tiered subscription plans or per-project pricing options.

• Pricing: freemium

Specifications

Other tools in this category

• Notle Ai
• Mentalyc
• MedARC

Compare tools in this category

Visit Lavo AI